Dec 2022: Atezolizumab (Tecentriq, Genentech, Inc.) an amince da shi ta Cibiyar Abinci da Magunguna (FDA) don manya da marasa lafiya na yara tare da sarcoma mai laushi mara kyau ko metastatic alveolar.
Dec 2021: An amince da waɗannan magunguna masu zuwa zuwa kwanan wata don maganin ciwon hanta:. Da fatan za a bincika bayanan rubutawa kafin shan magani. Atezolizumab Avastin (Bevacizumab) Bevacizumab Cabometyx (Cabozantinib-SM..
Nov 2021: Hukumar Abinci da Magunguna ta amince da atezolizumab (Tecentriq, Genentech, Inc.) don maganin adjuvant a cikin marasa lafiya tare da mataki na II zuwa IIIA ciwon huhu mara ƙaranci (NSCLC) wanda ciwace-ciwacen su ya ƙunshi PD-L1 magana o..